Pirjo Nuutila Selected Research

Deoxyglucose (2 Deoxy D glucose)

12/2021	18F-FDG positron emission tomography/computed tomography of cardiac implantable electronic device infections.
1/2016	Femoral Bone Marrow Insulin Sensitivity Is Increased by Resistance Training in Elderly Female Offspring of Overweight and Obese Mothers.
1/2016	Myocardial glucose uptake in patients with the m.3243A > G mutation in mitochondrial DNA.
1/2012	Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity.
12/2011	Mitochondrial diabetes is associated with insulin resistance in subcutaneous adipose tissue but not with increased liver fat content.
12/2009	Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation.
3/2009	m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction.
5/2008	Pancreatic glucose uptake in vivo in men with newly diagnosed type 1 diabetes.
9/2005	Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron-emitting tomography study.
9/2003	Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pirjo Nuutila Research Topics

Disease

54	Insulin Resistance 04/2021 - 08/2002
43	Obesity 04/2022 - 07/2002
43	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2002
32	Weight Loss (Weight Reduction) 12/2022 - 07/2003
31	Hyperinsulinism (Hyperinsulinemia) 01/2021 - 04/2002
15	Morbid Obesity 01/2021 - 05/2015
10	Inflammation (Inflammations) 01/2021 - 11/2003
9	Hyperemia 11/2014 - 06/2002
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2014 - 01/2002
6	Atherosclerosis 01/2021 - 01/2002
6	Heart Failure 01/2021 - 07/2003
5	Atherosclerotic Plaque (Atheroma) 01/2020 - 12/2011
5	Glucose Intolerance 01/2018 - 07/2004
5	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2008 - 08/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2004
4	Hyperglycemia 01/2017 - 05/2003
4	Fabry Disease (Fabry's Disease) 05/2013 - 10/2006
3	Neoplasms (Cancer) 04/2022 - 11/2003
3	Myocardial Infarction 12/2020 - 01/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 09/2010
3	Overweight 01/2018 - 01/2016
3	Hypertension (High Blood Pressure) 01/2018 - 09/2002
3	Non-alcoholic Fatty Liver Disease 01/2014 - 01/2009
2	Nervous System Diseases (Neurological Disorders) 12/2022 - 04/2021
2	Infections 12/2021 - 01/2002
2	Body Weight (Weight, Body) 01/2021 - 02/2003
2	Abdominal Obesity 01/2021 - 09/2005
2	Rheumatoid Arthritis 01/2021 - 02/2013
2	Feeding and Eating Disorders (Eating Disorder) 01/2021 - 01/2018
2	Hyperaldosteronism (Conn Syndrome) 01/2021 - 12/2020
2	Hypercholesterolemia 01/2020 - 01/2003
2	Fatty Liver 01/2019 - 01/2018
2	Prediabetic State (Prediabetes) 01/2019 - 01/2018
2	Maternal Obesity 07/2018 - 01/2016
2	Hyperphagia (Overeating) 01/2017 - 03/2015
2	Pain (Aches) 01/2017 - 06/2004
2	Hypoxia (Hypoxemia) 02/2012 - 07/2010
2	Hyperplasia 11/2008 - 04/2007
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2002 - 01/2002
1	Atrophy 12/2022

Drug/Important Bio-Agent (IBA)

65	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2002
48	Insulin (Novolin)FDA Link 01/2022 - 04/2002
19	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2022 - 08/2002
17	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 03/2007
16	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 09/2003
16	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 04/2002
11	Rosiglitazone (Avandia)FDA Link 09/2017 - 12/2002
10	Deoxyglucose (2 Deoxy D glucose)IBA 12/2021 - 09/2003
10	LipidsIBA 11/2020 - 05/2006
9	Opioid Analgesics (Opioids)IBA 01/2022 - 03/2015
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2009
7	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 12/2002
7	Triglycerides (Triacylglycerol)IBA 01/2018 - 11/2006
6	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 03/2015
5	CholesterolIBA 01/2017 - 01/2002
5	AdiponectinIBA 09/2012 - 07/2007
4	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021 - 03/2015
4	oxidized low density lipoproteinIBA 01/2019 - 07/2004
4	Oxygen (Dioxygen)IBA 01/2016 - 02/2003
3	EndocannabinoidsIBA 01/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2003
3	CannabinoidsIBA 01/2022 - 12/2015
3	dapagliflozinIBA 01/2021 - 01/2019
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 11/2015
3	carfentanil (carfentanyl)IBA 01/2020 - 11/2015
3	AdipokinesIBA 01/2016 - 01/2009
3	margaric acid (heptadecanoic acid)IBA 01/2015 - 07/2004
3	alpha-Galactosidase (Beano)IBA 01/2012 - 10/2006
2	Adenosine A2B ReceptorIBA 04/2022 - 01/2020
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 05/2006
2	Secretin FDA Link 01/2022 - 01/2021
2	FluorineIBA 04/2021 - 09/2003
2	C-Reactive ProteinIBA 01/2021 - 01/2019
2	metomidateIBA 01/2021 - 12/2020
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 12/2020
2	Lipoproteins (Lipoprotein)IBA 04/2020 - 01/2019
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019 - 01/2019
2	AcidsIBA 01/2018 - 11/2003
2	Apolipoprotein B-100 (Apo B 100)IBA 02/2016 - 12/2011
2	ApolipoproteinsIBA 02/2016 - 01/2002
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2016 - 12/2011
2	globotriaosylceramide (globotriosylceramide)IBA 05/2013 - 01/2012
2	Aminophylline (Carine)FDA LinkGeneric 02/2012 - 07/2010
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2012 - 07/2010
2	Trimetazidine (Vastarel)IBA 07/2011 - 09/2008
2	EnzymesIBA 04/2010 - 08/2008
2	PPAR gammaIBA 04/2009 - 01/2006
2	Dihydroxyphenylalanine (Dopa)IBA 03/2009 - 01/2006
2	LeptinIBA 01/2009 - 06/2003
2	Indicators and Reagents (Reagents)IBA 10/2006 - 08/2006
2	PPAR-gamma AgonistsIBA 12/2005 - 02/2003
2	Pravastatin (Pravachol)FDA LinkGeneric 07/2004 - 01/2003

Therapy/Procedure

28	Bariatric Surgery 12/2022 - 05/2013
11	Glycemic Control 12/2020 - 02/2003
7	Therapeutics 01/2021 - 06/2004
5	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 01/2017
5	Resistance Training 07/2018 - 01/2016
4	Gastrectomy 01/2022 - 01/2017
2	Radiotherapy 09/2009 - 07/2005
2	Caloric Restriction 01/2009 - 01/2009